Drugs in R & D

, Volume 5, Issue 3, pp 182–183 | Cite as

Tramadol — Biovail Corporation

Adis R&D Profile

Keywords

Tramadol Venlafaxine Mirtazapine Serotonin Syndrome Tramadol Hydrochloride 

References

  1. 1.
    Biovail Corporation. Biovail NDA For Ralivia ER — Tramadol Extended Release Tablets — Accepted for Review. Media Release: 26 Feb 2004. Available from URL: http://www.biovail.com Google Scholar
  2. 2.
    Biovail Corporation. Biovail Submits NDA for Ralivia Flash-Dose. Media Release: 11 Mar 2004. Available from URL: http://www.biovail.com Google Scholar
  3. 3.
    Houlihan DJ. Serotonin syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine. Annals of Pharmacotherapy 38: 411–3, No. 3, Mar 2004PubMedCrossRefGoogle Scholar
  4. 4.
    Biovail Corporation. Biovail Presents Tramadol Results at American College of Rheumatology. Media Release: 28 Oct 2002. Available from URL: http://www.biovail.com Google Scholar
  5. 5.
    Biovail Corporation. Biovail reports second positive phase III clinical result for tramadol extended release formulation. Media Release [3 pages], 14 Jan 2002. Available from URL: http://www.biovail.com Google Scholar

Copyright information

© Adis Data Information BV 2004

Personalised recommendations